Lei Wang
王蕾
Lei Wang (王蕾) is a partner at FreeS Fund (峰瑞资本), where she leads biotech and healthcare investing. She joined as an executive director by 2020 and was later promoted to partner, a role she held as of 2023-2024 . Her focus is on biotechnology-driven diagnostics and innovative drug development . She has been recognized by industry lists including from Zero2IPO, PEDaily and ChinaVenture , as well as by 清科创业&投资界 and 母基金研究中心 for her work as a female investor in venture capital .
AI-generated — may contain errors, please verify.
Coverage
Sex Differences in the Immune System and Their Implications | FreeS Research Institute
From Cancer to Lupus: What Health Secrets Hide in the Immune System's Gender Divide? From Cancer to Lupus: What Health Secrets Hide in the Immune System's Gender Divide? From Cancer to Lupus: What Health Secrets Hide in the Immune System's Gender Divide?
Decoding Aging, Combating Aging | FreeS Fund Report
The Secret of "Aging Without Decline"
World Book Day | The Books That Give Us "High Energy"
Crossover Book Recommendations from Investors and Business Writers
FreeS Fund 2023 Year in Review: Take the Long View
In 2024, hold onto hope, keep pushing upward, and do what's right rather than what's easy.
FreeS Fund's 8th Anniversary — Welcome Aboard, Let's Go Further Together
Discover more possibilities together.
FreeS Fund's Seventh Anniversary: Working Together to Go Further
Welcome to the team.
Women Rising: 18 Voices from the World of Entrepreneurship | FreeS Fund International Women's Day Special
The traits that lead to success know no gender. May your journey of discovery be filled with wonder.
How Does Single-Cell Sequencing Help You Understand the 40 Trillion Cells in Your Body? | 2021 FreeS Fund Annual Investor Summit
How Single-Cell Sequencing Is Revolutionizing Biomedicine
"There Will Come a Moment When Technology Defeats Human Experience" | A Conversation with FreeS Fund
"There will come a moment when technology surpasses human experience."
FreeS Fund Earns Ten Honors from Zero2IPO, PEDaily, ChinaVenture & GEW, CVCRI, ChinaRong360, Wanbang RB, and Lancha Consumer | FreeS Matters
Continuously hiring investors
Live at 10 AM Tomorrow | New Opportunities in the Changing Landscape of Drug R&D
See you tomorrow at 10 a.m. sharp.
How Should We Think About the Present and Future of Drug R&D? | FreeS Fund Dialogue Vol. 2 — Final 2 Days to Register
What new variables and opportunities are emerging in the drug development industry?
FreeS Fund Report 25: Food Investment Through the Lens of China's Dietary Structure
What will we eat in the future?
New Opportunities Amid the Great Transformation in Drug R&D | FreeS Fund Dialogue Session 2 Now Open for Registration
Breakthroughs and Acceleration in New Drug R&D
Biotech Firms Raise Nearly 4 Billion Yuan, Consumer Companies Land Over 1.4 Billion | FreeS Family Funding Roundup · August
We've also released three short videos this week — follow us to check them out.
How to Break Through Innovation with the Power of Interdisciplinary Collaboration? | FreeS Fund Biomedical and Pharmaceutical Investment Summit Transcript
What should you do if you discover a mismatch between technology and market?
Blue Ocean Strategy: How Early-Stage Biopharma Startups Can Break Through and Win with Big Pharma | FreeS Fund 2020 Biopharma Summit Session 3 — Registration Open
From "Me Worse" to "First in Class": How Can Biopharma Companies Compete Through Differentiation?
Beyond the "Narrow Door": A Real-World Portrait of Early-Stage Frontier Biotech Entrepreneurship in China | FreeS Fund 2020 Biotech Summit Registration Now Open
Will Today’s US Biotech Become China’s Tomorrow?
A Job Posting, Three Events | Frees Fund
Looking forward to your participation.
FreeS Fund Healthcare Open Day Is Here: Entering the Grand Era of Biomedical Innovation
Looking for China's Genentech, Moderna, Alnylam, Spark, Nimbus Therapeutics
"Nuoxin Chuanglian" Raises $15 Million in Funding | FreeS Fund Deal News
A new-generation leader in the life sciences marketing space.
Be Long-Term Greedy, Be a True Hero | FreeS Fund 2019 CEO Annual Meeting
Let's Go Further Together
